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Background: There is wide variation in the psychosocial response to false-positive mammography. We aimed to
assess whether women having to wait longer to exclude cancer had increased psychosocial consequences that
persisted after cancer was ruled out.
Findings: We selected women with false-positive mammography (n = 272), screened for breast cancer in
Copenhagen and Funen (Denmark) over a 1-year period. We measured psychosocial consequences immediately
before women attended their recall visit and 1, 6, 18 and 36 months after women received their final diagnosis.
After women were told that cancer had been ruled out, adverse psychosocial consequences decreased with time.
We found no statistically significant differences between women who had cancer ruled out immediately at the
recall visit (waiting time of 0) and women who had to wait longer before cancer was ruled out (waiting times 1-30,
30-120 and > 120 days), when psychosocial consequences were measured via a condition-specific questionnaire
(Consequences of Screening in Breast Cancer) at 5 time points (0, 1, 6, 18 and 36 months after cancer exclusion).
Conclusion: We did not confirm that waiting time was associated with worse long-term psychosocial consequences
but type II error (failure to detect a true difference) might be a plausible explanation for our results.Introduction
We have shown in a cohort of women screened with
mammography and followed-up for 36 months that
false-positives were associated with negative long-term
psychosocial consequences [1]. Moreover, in the same
cohort, we have shown the invasiveness of the down-
stream procedures does not influence the degree of
psychosocial consequences: women having non-
invasive procedures suffers the same degree of nega-
tive consequences as those having invasive procedures
[2]. Yet, there is wide variation in the psychosocial re-
sponse to false-positives and it would be clinically
relevant to find predictors of increased psychosocial
harm [3-8].
In the critical period between positive screening test
and the final diagnostic test that excludes cancer,
women often think that they have a fatal disease
[9,10]. This period may be particularly damaging in
women caught up in an endless cycle of testing [11],* Correspondence: bruno.heleno@sund.ku.dk
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unless otherwise stated.i.e. women who keep having unclear results and who
are asked to repeat diagnostic tests over a period of
weeks or months. Thus, in our cohort, we now
wanted to assess whether women having to wait lon-
ger for cancer exclusion had increased adverse psy-
chosocial consequences that persisted after cancer
was ruled out.Materials and methods
This paper is a post-hoc subgroup analysis of an
earlier fixed cohort study [1]. We selected women
with false-positive mammography, which enrolled
women aged 50 to 69 years in two mammography
screening programmes (Copenhagen and Funen,
Denmark) between June 3, 2004 and June 2, 2005.
Details of the original cohort have been previously
reported [1].
The exposure of interest (waiting time until cancer
exclusion) was calculated from the administrative re-
cords as the period between the day women called
to book an appointment after receiving the recall let-
ter and the date of final diagnosis. We did not ex-
pect waiting time to have a linear effect in. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ical difference would be between receiving the diag-
nosis in the same day and having to wait until
getting the diagnosis [12]. Also, an earlier study
about anxiety related to mammography screening
found a non-linear relationship between anxiety and
time until the first diagnostic test [13]. To address
the possibility of non-linear effects waiting time was
categorised. Because we could not find literature to
guide the choice of categories, we used the following
arbitrary cut-offs: 0 days, 1-30, 30-120 and > 120
days.
The main outcome was psychosocial consequences
of screening. It was assessed through a condition-
specific questionnaire – the Consequences of Screen-
ing in Breast Cancer (COS-BC) [14-16]. We used the
sum-score of all 29 items in part-1 of the COS-BC.
This score is supported by a confirmatory factor ana-
lysis [15] and was used in an earlier study [2]. The
outcome was assessed at 5 points in time: women
were invited to complete the questionnaire at the re-
call clinic (immediately before their consultation) and
at 1, 6, 18 and 36 months after cancer had been ex-
cluded [1].
We have collected data on four potential confounders
with the first questionnaire: age, social class,Table 1 Differences in psychosocial consequences of false-po




Before meeting with the doctor After can
0 months 1 month
Crude average psychosocial consequences Estimate
0 days 22.78 9.63
(n = 179) (19.14 to 26.42) (7.46 to 11
1-30 days 27.65 12.87
(n = 46) (18.51 to 36.79) (6.18 to 19
31-120-days 20.14 5.93
(n = 36) (13.14 to 27.15) (1.56 to 10
>120 days 21.00 9.29
(n = 11) (4.76 to 37.24) (3.24 to 15
Adjusted average difference compared with women
1-30 days 2.23 0.42
(-6.43 to 10.9) (-4.39 to 5
31-120-days −4.44 −3.90
(-13.38 to 4.51) (-10.7 to 2
>120 days −1.90 −0.14
(-15.81 to 12) (-9.75 to 9
*Positive values mean that psychosocial consequences were worse for women need
same day. The difference was adjusted for age, social class, employment, and whet
truncated at 0 since this was the lowest possible score.employment, and whether the woman lived alone. Age
was treated as a continuous variable.
The mean score for each outcome throughout time
was analysed using linear regression models. We used
both crude models and models adjusted for the four
potential confounders. We defined significance at P < 0.05.
Scales set to missing were not included in the analyses. All
analyses were performed with SAS 9.3 (SAS Institute, Inc.,
Cary, NC).
The study was approved by the Danish Data Protec-
tion Agency, 2007-41-0777. Approval from the ethics
committee was not required. In accordance to Danish
law, assessment by an ethics committee is only re-
quired when new interventions are being tested or if
biological material is collected and this study con-
sisted in a survey. All participants provided consent
when they replied to the first questionnaire.
Results
Of the 272 women with false-positive findings, 179 had
cancer ruled out immediately at the recall clinic (waiting
time of 0 days), 46 women waited between 1 and 30 days,
36 women between 31 and 120 days, and 11 women
waited more than 120 days until cancer was excluded.
Table 1 and Figure 1 summarise the mean psycho-
social consequences for each subgroup. At the baselinesitive mammography in women who had different waiting
cer had been ruled out
6 months 18 months 36 months
(95% confidence interval)
7.26 5.41 6.46
.80) (5.02 to 9.50) (3.68 to 7.14) (4.18 to 8.74)
8.61 7.57 4.17
.55) (3.03 to 14.19) (2.10 to 13.03) (1.20 to 7.15)
5.56 3.86 5.37
.29) (2.16 to 8.95) (0.65 to 7.06) (0 to 11.41)†
1.00 9.20 2.44
.33) (0 to 2.96)† (0 to 23.38)† (0.59 to 4.30)
who waited 0 days* Estimate (95% confidence interval)
−1.71 −0.08 −2.67
.23) (-5.8 to 2.37) (-3.83 to 3.67) (-7.3 to 1.95)
−1.93 −1.35 −1.58
.9) (-6.88 to 3.03) (-5.72 to 3.02) (-7.12 to 3.96)
−5.75 3.59 −3.67
.46) (-16.69 to 5.19) (-4.82 to 12.01) (-11.77 to 4.42)
ing to wait longer, compared with women that had cancer excluded in the
her the woman lived alone. †The lower bound of the confidence interval was
Figure 1 Psychosocial consequences of false-positive mammography in women who had different waiting times until cancer exclusion. For each
of the groups defined by the waiting time from the day women contacted the recall clinic to final diagnosis, we assessed psychosocial consequences
at five assessment points (baseline and 1, 6, 18, and 36 months after final diagnosis).
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consequences. After women were told that cancer had
been ruled out, adverse psychosocial consequences de-
creased with time in all subgroups. Table 1 also shows
that, in the 4 assessment points after cancer was ruled
out, there were no statistically significant differences be-
tween women who had to wait longer for their final
diagnosis (waiting times 1-30, 30-120 and > 120 days)
and women who had cancer ruled immediately at the
recall visit (waiting time of 0).
Discussion
We assessed psychosocial consequences at five different
assessment points, but the interpretation of the first is
different from the last four. The first consists of the
assessment at the recall clinic, when women only knew
that they had an abnormal screening mammography.
This assessment point shows that women in the sub-
groups we defined for this paper were comparable at
baseline. The other four assessment points were after
women had been told they were free from cancer: we
found no association between waiting time until cancer
exclusion and the degree of psychosocial consequences
at 1, 6, 18 and 36 months after cancer exclusion.
This was unexpected: qualitative studies stress that
women are anguished while they wait for the results
[9,10], and it was reasonable to think that the longer the
wait, the worse women might feel in the long-term. A
cohort study found that women that had to wait 6 or 12
months until final diagnosis were more distressed than
women who had cancer ruled out after clinical mam-
mography [17-19]; but, to the best of our knowledge, no
one tried to replicate this result since. The closest comes
from a cohort which included women with false-positivemammography and breast cancer. It found a non-linear
effect of time on anxiety measured 7-8 months after
mammography: women with very short (≤ 7 days) or
very long periods (> 60 days) were more distressed than
an intermediate group [13].
The main strengths of the present study are in the
characteristics of the original cohort study. It used a vali-
dated condition-specific questionnaire, it was designed
prospectively with repeated measurements to avoid re-
call bias, and it has one of the longest durations of
follow-up for surveys of psychosocial harm (36 months).
In addition, this study measured the main exposure of
interest (waiting time) from the administrative records,
which minimises recall bias.
This study’s results are limited by the small number of
women included in some of the subgroups. The cohort
study that suggested increased distress [17-19] had 100
women that needed to wait 6 or 12 months until final
diagnosis. Our study had 11 women in the > 60 days cat-
egory. Hence, lack of an association may just be due to
low power. One further limitation is that we do not have
data about how long women waited between receiving
the recall letter and calling the screening clinic. Thus, it
is possible that we misclassified women that waited
some days before calling the screening clinic with a wait-
ing time of 0. If waiting time was associated with psy-
chosocial consequences, this misclassification would
decrease the contrast between subgroups which could
also explain or negative findings.
Conclusion
This study tried to assess if there is a sub-group of
women with false-positive results at particularly high
risk of psychosocial harm. We did not confirm our a
Heleno et al. Journal of Negative Results in BioMedicine  (2015) 14:8 Page 4 of 4priori hypothesis: that waiting time was associated with
worse long-term psychosocial consequences in women
with false-positive screening mammography. However,
type II error (failure to detect a true difference) might be
a plausible explanation for our results.
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